158 results match your criteria: "centre de compétence des maladies vasculaires rares[Affiliation]"
Eur Stroke J
January 2025
Row Fogo Centre for Research into Ageing and the Brain, and UK Dementia Research Institute, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Purpose: Cerebral small vessel disease (cSVD) is a highly prevalent disorder leading to physical, cognitive and functional decline. We report key barriers in the management of individuals with cSVD, the potential benefit of cSVD-dedicated health services, and evidence from existing models of care for adults with cSVD.
Methods: We examined information from a scientific seminar developed between seven experts in cSVD during the eighth European Stroke Organisation Conference that discussed the optimal health care for adults with cSVD and what health services dedicated to cSVD should include.
JAMA Neurol
January 2025
Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Retina
October 2024
Ophthalmology Department, Hôpital Lariboisière, APHP and Université Paris-Cité, France.
Purpose: Qualitative and quantitative analyzes of retinal arteriolar tortuosity (RAT) in patients with COL4A1 and COL4A2 mutations to identify a tortuosity index (TI) threshold for detecting increased RAT.
Methods: Fifty-two eyes of 28 patients were included. Group 1 included eyes with a normal arteriolar pattern (n=19, 37%), group 2 included eyes with moderately increased arteriolar tortuosity (n=13, 25%), and group 3 included eyes with typical abnormal arteriolar tortuosity (n=20, 38%).
Rev Med Interne
October 2024
Unité de lymphologie, Centre national de référence des maladies vasculaires rares (lymphœdème primaire), hôpital Cognacq-Jay, 15, rue Eugène-Millon, 75015 Paris, France. Electronic address:
Invest Ophthalmol Vis Sci
September 2024
Ophthalmology Department, AP-HP, Hôpital Lariboisière, Université Paris Cité, Paris, France and Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Hôpital Lariboisière, APHP, Paris, France.
Purpose: To assess the correspondence between interdigitation zone (IZ) reflectivity, ellipsoid zone (EZ) loss, inner retinal layer reflectivity, patterns of capillary dilation, and telangiectasia in eyes with early macular telangiectasia type 2 (MacTel).
Patients And Methods: Twenty-eight eyes of 22 patients with grade 0-2 MacTel (according to the MacTel project classification) and 28 healthy control eyes were included in this study. Multimodal imaging, including optical coherence tomography (OCT) angiography, adaptive optics flood illumination ophthalmoscopy (AO-FIO) and blue light reflectance (BLR), was performed.
Rev Med Interne
December 2024
Unité de médecine translationnelle et thérapies ciblées, hôpital Necker-Enfants-Malades, université Paris Cité, 149, rue de Sèvres, 75015 Paris, France.
Retina
July 2024
Ophthalmology Department, AP-HP, Hôpital Lariboisière, Université Paris Cité, Paris, France; and.
Purpose: To describe the progression from outer retinal neovascularization (ORNV) to exudative subretinal new vessels (SRNVs) in idiopathic macular telangiectasia type 2.
Methods: A total of 135 patients (270 eyes) imaged with optical coherence tomography angiography were included.
Main Outcome Measures: Ellipsoid zone loss, outer retinal hyperreflectivity, ORNV, and SRNVs.
J Cereb Blood Flow Metab
July 2024
Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.
A major hurdle to therapeutic development in cerebral small vessel diseases is the lack of in-vivo method that can be used repeatedly for evaluating directly cerebral microvessels. We hypothesised that Adaptive Optics (AO), which allows resolution images up to 1-2 μm/pixel at retinal level, could provide a biomarker for monitoring vascular changes in CADASIL, a genetic form of such condition. In 98 patients and 35 healthy individuals, the wall to lumen ratio (WLR), outer and inner diameter, wall thickness and wall cross-sectional area were measured in a parapapillary and/or paramacular retinal artery.
View Article and Find Full Text PDFAm J Med Genet A
November 2023
UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, UFR des Sciences de Santé, INSERM-University of Burgundy, Dijon, France.
Grange syndrome (GRNG-MIM#135580) is a rare recessive disorder associating variable features including diffuse vascular stenosis, brachysyndactyly, osteopenia with increased bone fragility, cardiac malformations, and variable developmental delay. Since its first description in 1998, only 15 individuals from 10 families have been reported, carrying homozygous or compound heterozygous frameshift or nonsense variants in YY1AP1. In a patient with cutaneous and bone syndactyly and a hemorrhagic stroke at the age of 16 months, consistent with a clinical diagnosis of GRNG, we performed exome sequencing after negative array-CGH and congenital limb malformation panel results.
View Article and Find Full Text PDFClin Genet
November 2023
Equipe INSERM UMR1231, Génétique des Anomalies du Développement, FHU TRANSLAD, Université Bourgogne Franche-Comté, Dijon, France.
Brain
September 2023
Department of Internal Medicine, Division of Medical Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Moyamoya disease, a cerebrovascular disease leading to strokes in children and young adults, is characterized by progressive occlusion of the distal internal carotid arteries and the formation of collateral vessels. Altered genes play a prominent role in the aetiology of moyamoya disease, but a causative gene is not identified in the majority of cases. Exome sequencing data from 151 individuals from 84 unsolved families were analysed to identify further genes for moyamoya disease, then candidate genes assessed in additional cases (150 probands).
View Article and Find Full Text PDFRetina
September 2023
Ophthalmology Department, AP-HP, Hôpital Lariboisière, and Université Paris Cité, Paris, France.
Hum Genomics
March 2023
Inserm UMR-S1141, Université Paris Cité, Paris, France.
Background: Moyamoya angiopathy (MMA) is a rare cerebrovascular condition leading to stroke. Mutations in 15 genes have been identified in Mendelian forms of MMA, but they explain only a very small proportion of cases. Our aim was to investigate the genetic basis of MMA in consanguineous patients having unaffected parents in order to identify genes involved in autosomal recessive MMA.
View Article and Find Full Text PDFClin Case Rep
February 2023
AP-HP, GHU Paris Saclay, Hôpital Raymond Poincaré, Centre de référence des syndromes d'Ehlers-Danlos non vasculaires, UMR1179 INSERM Garches France.
Kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is a rare genetic disorder combining congenital hypotonia, congenital/early onset and progressive kyphoscoliosis, and generalized joint hypermobility. Vascular fragility is another characteristic of the disease rarely described. We report a severe case of kEDS-PLOD1 with several vascular complications leading to difficulties in disease management.
View Article and Find Full Text PDFStroke
April 2023
Department of Neurology (A.D., L.G., E.J.), Lariboisière Hospital, AP-HP, Paris, France.
Background: In CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy), clinical severity is not related to the total burden of white matter hyperintensities (WMHs), presumably because of heterogeneous underlying tissue alterations. We aimed to investigate whether WMHs in the corpus callosum (WMH) are due to secondary degeneration and related to clinical severity.
Methods: We evaluated data from 228 CADASIL patients included in an ongoing prospective cohort with available 3-dimensional fluid-attenuated inversion recovery magnetic resonance imaging sequences.
Rev Med Interne
February 2023
Unité de lymphologie, centre national de référence des maladies vasculaires rares (lymphœdème primaire, malformations lymphatiques), hôpital Cognacq-Jay, 15, rue Eugène-Millon, 75015 Paris, France. Electronic address:
Cancers (Basel)
November 2022
Department of Lymphology, Centre National de Référence des Maladies Vasculaires Rares (Lymphoedèmes Primaires), Hôpital Cognacq-Jay, 15, rue Eugène-Millon, 75015 Paris, France.
Genital lymphedema may affect males and females after cancer treatment (gynecological, such as cervical, uterine or ovarian, melanoma, prostate, anus…). It is frequently associated with lower limb lymphedema, and is responsible for discomfort, cosmetic disfigurement and functional disturbances. Impacts on body image, sexual function and quality of life are major, and difficult to explore because cancer treatment itself and lymphedema are so closely interwoven.
View Article and Find Full Text PDFCereb Circ Cogn Behav
March 2022
Service de Neurologie, Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Oeil, Hôpital Lariboisière, AP-HP, Paris 75010, France.
and genes encode the alpha1 and the alpha2 chains of type IV collagen, a key component of basement membranes. Mutations located in the coding sequence of genes are responsible for an autosomal dominant (AD) cerebral angiopathy that manifest in either adults, children or fetuses. The most typical among such mutations are missense glycine mutations in the triple helix.
View Article and Find Full Text PDFBackground: Vascular Ehlers-Danlos syndrome (vEDS) is a rare inherited connective tissue disorder due to pathogenic variants in leading to medium-size-artery (MSA) dissection, aneurysm, rupture. Aortic lesions are rarer and less investigated. The objective was to describe the distribution of MSA and aortic lesions and the type of COL3A1 variants in a multicentric cohort of 330 adult vEDS patients.
View Article and Find Full Text PDFRev Prat
June 2022
Unité de lymphologie, Centre national de référence des maladies vasculaires rares (lymphoedèmes primaires), hôpital Cognacq-Jay, Paris, France.
MEDICAL MANAGEMENT OF LIMB LYMPHEDEMA. Lymphedema results from impaired lymphatic transport then tissue modifications (adipose deposition, thickening skin) leading to an increased limb volume. Lymphedema management is based on complete decongestive physiotherapy (multilayer low stretch bandage, manual lymph drainage, skin care, exercises).
View Article and Find Full Text PDFEur J Med Genet
September 2022
AP-HP, Hôpital Européen Georges Pompidou, Département de Génétique, Centre de Référence des Maladies Vasculaires Rares and VASCERN MSA European Reference Centre, Paris, France; INSERM, U 970, Paris Centre de Recherche Cardiovasculaire-PARCC, Paris, France.
Vascular Ehlers-Danlos syndrome (vEDS) is a rare genetic disorder clinically characterized by vascular, intestinal and uterine fragility and caused by heterozygous pathogenic variants in the COL3A1 gene. Management of patients with vEDS is difficult due to the unpredictability of the events and clear recommendations on the care of adults and children with vEDS are lacking. Therefore, we aimed to collect data on the current strategy of surveillance and monitoring of vEDS patients by expert centers in continental Europe and Great Britain, as a first step towards a consensus statement.
View Article and Find Full Text PDFBull Cancer
July 2022
Hématologie clinique, Centre Léon Bérard, Lyon, France; Centre de Recherche de Cancérologie de Lyon, Centre Léon Bérard, Inserm U1052, Lyon, France; France Intergroupe de la leucémie myéloïde chronique Fi-LMC, Lyon, France. Electronic address:
Tyrosine kinase inhibitors targeting the BCR-ABL1 oncoprotein represent an outstanding progress in chronic myeloid leukemia and long-term progression-free survival has become a reality for a majority of patients. However, tyrosine kinase inhibitors may at best chronicize rather than cure the disease thus current recommendation is to pursue treatment indefinitely. As a consequence, high quality treatment and care must integrate optimal disease control and treatment tolerability.
View Article and Find Full Text PDFRev Med Interne
September 2022
Service de médecine vasculaire, groupe hospitalier Paris Saint-Joseph, 184, rue Raymond-Losserand, 75014 Paris, France.
Rev Med Interne
July 2022
Unité de Lymphologie, Centre national de référence des maladies vasculaires rares (lymphœdème primaire, malformations lymphatiques), Hôpital Cognacq-Jay, 15, rue Eugène Millon, 75015 Paris, France. Electronic address:
PLoS Genet
March 2022
Université de Paris, INSERM, U970, Paris Cardiovascular Research Centre, Paris, France.
Vascular Ehlers-Danlos syndrome is a rare inherited disorder caused by genetic variants in type III collagen. Its prognosis is especially hampered by unpredictable arterial ruptures and there is no therapeutic consensus. We created a knock-in Col3a1+/G182R mouse model and performed a complete genetic, molecular and biochemical characterization.
View Article and Find Full Text PDF